Company Recordati OTC Markets

Equities

RCDTF

IT0003828271

Pharmaceuticals

Market Closed - OTC Markets 15:25:52 25/01/2024 GMT 5-day change 1st Jan Change
51.6 USD -0.73% Intraday chart for Recordati -.--% +12.17%

Business Summary

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (32.1%).

Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).

Number of employees: 4,455

Sales per Business

EUR in Million2022Weight2023Weight Delta
Specialty & Primary Care
65.7 %
1,258 67.9 % 1,368 65.7 % +8.75%
Rare Diseases
34.3 %
596 32.1 % 715 34.3 % +19.96%

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe
56.4 %
1,084 58.5 % 1,175 56.4 % +8.37%
America
19.0 %
324 17.5 % 395 19.0 % +22.06%
Italy
15.2 %
277 15.0 % 317 15.2 % +14.36%
Australasia
6.7 %
115 6.2 % 140 6.7 % +21.69%
Africa
2.7 %
53 2.9 % 56 2.7 % +3.96%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 30/11/21
Director of Finance/CFO 54 31/10/19
Chairman 52 28/04/98
Chief Tech/Sci/R&D Officer - 30/06/17
Director/Board Member 71 28/04/20
Investor Relations Contact 51 30/09/20
General Counsel - 31/03/23
General Counsel - 31/03/23
Human Resources Officer - 31/12/22
Corporate Officer/Principal - 31/12/07

Members of the board

Members of the board TitleAgeSince
Director/Board Member 51 11/06/18
Director/Board Member 55 11/06/18
Chief Executive Officer 61 30/11/21
Chairman 52 28/04/98
Director/Board Member 49 28/04/20
Director/Board Member 51 28/04/22
Director of Finance/CFO 54 31/10/19
Director/Board Member 62 15/12/21
Director/Board Member 71 28/04/20
Director/Board Member 60 04/02/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,125,156 97,942,240 ( 46.83 %) 2,763,813 ( 1.322 %) 46.83 %

Shareholders

NameEquities%Valuation
CVC Advisers Ltd.
51.82 %
108,368,721 51.82 % 5 694 M $
Invesco Asset Management Ltd.
2.278 %
4,763,870 2.278 % 250 M $
RECORDATI
1.319 %
2,758,646 1.319 % 145 M $
Invesco Advisers, Inc.
0.5980 %
1,250,568 0.5980 % 66 M $
Amundi Asset Management SA (Investment Management)
0.3166 %
662,191 0.3166 % 35 M $
Manulife Investment Management Ltd.
0.1917 %
400,906 0.1917 % 21 M $
Didner & Gerge Fonder AB
0.1913 %
400,000 0.1913 % 21 M $
Mediolanum Gestione Fondi SGRpA
0.1795 %
375,478 0.1795 % 20 M $
FMR Investment Management (UK) Ltd.
0.1717 %
359,171 0.1717 % 19 M $
ATB Investment Management, Inc.
0.1603 %
335,132 0.1603 % 18 M $

Holdings

NameEquities%Valuation
2,758,646 1.32% 144,947,647 $
9,554,140 3.53% 28,464,554 $
43,103 0.71% 140,144 $

Company contact information

Recordati SpA

Via Matteo Civitali, 1

20148, Milan

+39 02 487871

http://www.recordati.it/
address Recordati(RCDTF)

Group companies

NameCategory and Sector
Household/Personal Care
Drugstore Chains
Pharmaceuticals: Major
Recordati Ilac San ve Tic AS
Medical Distributors

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.7 EUR
Average target price
52.64 EUR
Spread / Average Target
+8.09%
Consensus